Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers

Wu Hong,Min Zhao,Haozhe Li,Fanglan Peng,Fan Wang,Ningning Li,Hui Xiang,Yousong Su,Yueqi Huang,Shengyu Zhang,Guoqin Zhao,Rubai Zhou,Ling Mao,Zhiguang Lin,Yiru Fang,Qinting Zhang,Bin Xie
DOI: https://doi.org/10.1038/srep27584
IF: 4.6
2016-01-01
Scientific Reports
Abstract:Glial damage and immune dysfunction are involved in pathogenesis of schizophrenia. However, interaction between glial damage and immune dysfunction in schizophrenia is undefined. This study aims to compare plasma S100 calcium binding protein (S100B) levels between schizophrenia patients and healthy participants and to determine if immune markers are independently related with concentration of S100B in schizophrenia patients. Forty-one schizophrenia patients and thirty-three healthy volunteers were enrolled. Enzyme-linked immunosorbent assay (ELISA) was used to assess the concentrations of plasma S100B and inflammatory markers. We found that concentrations of S100B were elevated in schizophrenia patients than healthy participants (p < 0.05) and were negatively related with the severity of symptoms (p = 0.046). Receiver operating characteristic (ROC) curve analysis showed that different S100B levels between schizophrenia and healthy participants can be used as a clinical diagnostic factor (predictive value: 0.666, p = 0.015). Multiple linear regression analysis found that length of illness (Beta = −0.161), plasma levels of inflammatory regulation factors (including TGF-β1, logIL-23 and logIL-10) (Beta = 0.119, 0.475, 0.514) were independently associated with concentrations of S100B (Adjusted R2 = 0.897, p < 0.001). Therefore, our results suggest the possible function of S100B in pathogenesis of schizophrenia and implicate the important role of autoimmune response and balance to glial dysfunction in patients with schizophrenia.
What problem does this paper attempt to address?